PACT Act · Cancer Claims Updated July 2026 · By Marcus J. Webb

Head and Neck Cancer VA Claim: PACT Act Presumptive Guide (2026)

Head and neck cancers — including nasopharyngeal, oropharyngeal, laryngeal, hypopharyngeal, and salivary gland cancers — are among the PACT Act's most significant presumptive additions for veterans exposed to burn pits and airborne hazards. If you served in Southwest Asia, Afghanistan, or other qualifying locations and later developed one of these cancers, the PACT Act eliminates the most difficult evidentiary hurdle: proving the link between your exposure and your disease. This guide explains which cancers qualify, how VA rates them, what DC codes apply, and how to file a claim that accounts for both active disease and long-term residuals.
🩺

Diagnosed with Head or Neck Cancer?

REE Medical connects veterans with physicians experienced in VA oncology claims. They can provide medical opinions documenting exposure history, cancer diagnosis, and residual conditions to support the highest possible rating — including the mandatory six-month post-treatment review.

Learn About REE Medical's Cancer Claim Support →

claim.vet may receive a referral fee if you use this link. Veterans never pay more.

Which Head and Neck Cancers Are PACT Act Presumptives

The PACT Act of 2022 dramatically expanded VA's list of presumptive cancers for veterans exposed to toxic substances during military service. Head and neck cancers are among the most significant additions because these cancers are biologically linked to the types of carcinogens found in burn pit smoke, jet fuel fumes, and other airborne hazards common to post-9/11 deployment environments.

The following head and neck cancer types are recognized as presumptive conditions under the PACT Act:

Cancer TypeSiteNotes
Nasopharyngeal carcinomaUpper throat / back of nasal cavityAssociated with EBV and carcinogen exposure
Oropharyngeal carcinomaMiddle throat (tonsils, base of tongue)HPV-associated and carcinogen-linked
Hypopharyngeal carcinomaLower throatHigh association with toxic exposure
Laryngeal carcinomaVoice box (larynx)Strongly linked to inhaled carcinogens
Salivary gland cancerParotid, submandibular, sublingual glandsMultiple subtypes recognized
Squamous cell carcinoma of head/neckOral cavity, lip, floor of mouthBroad coverage of SCC subtypes
Thyroid cancerThyroid glandCovered under separate radiation/PACT pathway

These cancers are covered presumptively — meaning VA accepts that the link between your military service (and its toxic exposures) and your cancer is established by law. You do not need to submit a nexus letter or prove causation. You need to show you have the diagnosis and that you served in a qualifying location and time period.

PACT Act Eligibility Requirements

To receive presumptive service connection under the PACT Act for a head or neck cancer, you must meet the following criteria:

Qualifying Service Locations

Veterans who served in any of the following locations during the specified periods are eligible:

Open Burn Pit Registry

If you're not already registered in the Airborne Hazards and Open Burn Pit Registry, VA strongly encourages registration before filing. Registry participation supports your claim by creating an official record of your exposure acknowledgment, though it is not legally required for presumptive benefits.

Key Point: No Nexus Letter Required

Unlike non-presumptive cancer claims, PACT Act presumptive head and neck cancer claims do not require a nexus letter connecting your cancer to your service. The law creates the connection. However, strong claims still need detailed documentation of service history, exposure, and the diagnosis itself — and a physician's opinion can help ensure the highest possible rating for residuals.

DC Codes and Rating Structure for Head and Neck Cancers

One complexity of head and neck cancer VA claims is that different anatomical sites are rated under different Diagnostic Codes in 38 CFR Part 4. This matters because the residual conditions — what VA rates after treatment — depend on which DC applies to your primary cancer site.

Cancer SitePrimary DC CodeResidual DC Codes (Post-Treatment)
Nasopharynx, larynx, hypopharynxDC 6819 (malignant neoplasm, respiratory system)DC 6516 (laryngitis), DC 6819 (residual), DC 6820
Oropharynx, oral cavity, salivary glandsDC 7343 (malignant neoplasm, digestive system)DC 7205 (loss of jaw tissue), dysphagia residuals
ThyroidDC 7914 (malignant neoplasm, endocrine system)DC 7900 series (thyroid conditions)
Salivary glandDC 7343 or DC 6819 (site-dependent)Xerostomia, facial nerve residuals

During active cancer treatment — chemotherapy, radiation, surgery, or combination therapy — VA assigns a 100% rating regardless of the specific DC code. The DC code becomes most important when VA evaluates residual conditions after treatment completion.

The 100% Rating During Active Treatment

Under 38 CFR § 4.29, any active malignant neoplasm (cancer) that is service-connected receives a 100% disability rating while the cancer is being actively treated or while the cancer remains active. For head and neck cancer veterans, this means:

The 100% rating is not discretionary. If VA has service-connected your head or neck cancer and it is active or under treatment, you are entitled to a 100% rating by regulation. If VA has rated you lower during active treatment, this is an error that should be challenged through a supplemental claim or appeal.

The Six-Month Rule and Mandatory Post-Treatment Review

Under 38 CFR § 4.29, the 100% rating for active cancer is maintained for at least six months following the completion of treatment. This is a significant veteran-protective provision — VA cannot reduce your rating immediately when treatment ends. The minimum six-month period at 100% is guaranteed by regulation.

After this six-month period, VA is required to schedule a Compensation and Pension (C&P) re-examination. At this exam, the examiner evaluates:

If the cancer has recurred, the 100% rating is reinstated. If the cancer is in remission, VA must rate the residual conditions. This is where many veterans lose significant compensation — because VA may not fully account for all residuals if the veteran and their representative aren't prepared to document them.

Critical: Document All Residuals Before Your Review Exam

Head and neck cancer treatment often leaves permanent residuals: dysphagia (swallowing difficulty), xerostomia (dry mouth from radiation), dysphonia or aphonia (voice changes), facial nerve damage, lymphedema, dental damage from radiation, hearing loss from cisplatin chemotherapy, hypothyroidism from radiation or surgical removal. Each of these residuals can be rated separately. Before your six-month review exam, document every symptom you experience and discuss them with your physician.

Rating Residuals After Head and Neck Cancer Treatment

The long-term disability picture for head and neck cancer veterans often comes from residuals — the permanent damage left by the cancer itself and its treatment. These residuals can be rated separately and concurrently with each other and with the underlying cancer (if it recurs).

Laryngeal Residuals

Veterans who underwent laryngectomy (surgical removal of the larynx) or sustained radiation damage to the voice box face long-term functional impairment:

Swallowing and Digestive Residuals

Radiation to the throat and surgery affecting the pharynx often produce lasting dysphagia:

Salivary and Oral Residuals

Radiation therapy to the head and neck commonly destroys salivary gland function:

Chemotherapy Residuals

Cisplatin-based chemotherapy, commonly used for head and neck cancers, causes dose-dependent hearing loss:

Thyroid and Endocrine Residuals

Radiation to the neck often affects thyroid function, and thyroid removal produces permanent hormone deficiency:

Each Cancer Type: Detailed Overview

Nasopharyngeal Cancer

Nasopharyngeal carcinoma (NPC) develops in the nasopharynx — the upper part of the throat behind the nose. It is rated under DC 6819 (malignant neoplasms of the respiratory system). NPC is biologically linked to both Epstein-Barr virus (EBV) exposure and carcinogen exposure, making it a recognized occupational and environmental cancer. Veterans who worked in environments with high airborne carcinogen concentrations are at elevated risk. Treatment typically involves radiation and chemotherapy, producing significant residuals including hearing loss (auditory canal near the tumor field), cranial nerve damage, and pituitary dysfunction from radiation scatter.

Oropharyngeal Cancer

Oropharyngeal cancers — affecting the tonsils, soft palate, posterior pharyngeal wall, and base of tongue — are rated under DC 7343 (malignant neoplasms of the digestive system). This is one of the most common PACT Act head and neck cancer claims. Treatment involves radiation, chemotherapy, or transoral robotic surgery (TORS). Common residuals include dysphagia, trismus (difficulty opening the mouth), dental destruction from radiation, and lymphedema of the neck.

Laryngeal Cancer

Laryngeal cancer — affecting the glottis, supraglottis, or subglottis — is strongly associated with inhaled carcinogens and is rated under DC 6819. Veterans who received partial or total laryngectomy lose some or all of their natural voice and may require a tracheoesophageal prosthesis, electrolarynx, or esophageal speech. These functional impairments are highly ratable and should be carefully documented at every C&P examination. Radiation therapy to the larynx also produces laryngeal edema, fibrosis, and cartilage necrosis — each of which can support rating increases as residuals.

Hypopharyngeal Cancer

Hypopharyngeal carcinoma develops in the lower portion of the pharynx, near the entrance to the esophagus. It is typically associated with advanced disease at diagnosis and requires aggressive combined-modality treatment. The hypopharynx's proximity to the esophagus means treatment frequently produces severe dysphagia requiring feeding tube placement — a significant residual for rating purposes. It is rated under DC 7343 or DC 6819 depending on the predominant anatomical location.

Salivary Gland Cancer

Salivary gland malignancies — including mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma — can arise in the major salivary glands (parotid, submandibular, sublingual) or minor salivary glands throughout the oral cavity. They are rated under DC 7343 or DC 6819 depending on location. Treatment typically requires surgical excision and radiation. Significant residuals include facial nerve palsy from parotid surgery (rated under peripheral nerve codes), xerostomia from the remaining salivary tissue receiving radiation, and Frey's syndrome.

How to File Your Head and Neck Cancer VA Claim

Filing a PACT Act presumptive cancer claim involves several key steps:

  1. Obtain your complete service records. Request your DD-214 and service treatment records through the National Personnel Records Center (NPRC) if you don't have them. Your service history must establish that you served in a qualifying location during a qualifying period.
  2. Gather your medical records. Collect all records documenting your cancer diagnosis — pathology reports, imaging studies, biopsy results, oncologist notes, and treatment records (chemotherapy, radiation, surgery).
  3. Register in the Burn Pit Registry. If you haven't already, register at the VA Airborne Hazards and Open Burn Pit Registry website. This creates an official record of your exposure acknowledgment.
  4. File VA Form 21-526EZ. This is the standard VA disability compensation application. File online through VA.gov, by mail, or through a VSO (Veterans Service Organization).
  5. Request an effective date back to diagnosis or service. Discuss the effective date issue with an accredited representative — in some cases, the effective date can reach back to the date of your cancer diagnosis or even earlier under certain circumstances.
  6. Consider filing for all potential residuals immediately. If you are already post-treatment, file for every residual condition at the same time as your primary cancer claim to avoid delays and future effective date issues.
File Early — Effective Dates Matter

Your effective date for VA compensation is generally the date VA receives your claim, not the date your cancer was diagnosed or the date you completed treatment. Earlier filing means earlier payment. Under the PACT Act, some veterans may be eligible for retroactive benefits based on previously denied claims — consult a VA-accredited attorney to evaluate your specific situation.

Key Evidence for Your Head and Neck Cancer Claim

C&P Exam Preparation for Head and Neck Cancer Claims

The C&P examination is critical to your rating, particularly for the post-treatment residuals evaluation. Key preparation steps:

Before the Active Cancer Exam

Before the Six-Month Review Exam

Key Questions to Answer Clearly During the Exam

⚖️

Connect with a VA-Accredited Attorney

Head and neck cancer claims involve complex residuals ratings, effective date issues, and potential SMC eligibility. A VA-accredited attorney can evaluate your full claim picture and ensure you're receiving all benefits you're entitled to.

Find a VA-Accredited Attorney →

Related PACT Act and Cancer Guides

🎖️

Check Your PACT Act Eligibility

Head and neck cancer after burn pit exposure may qualify you for 100% VA disability. Find out where you stand — free, no phone calls required.

Check My Eligibility — Free →
✓ Free for veterans✓ No phone calls✓ VA-accredited attorneys

Official Sources & References

Editorial Standards: Written by Marcus J. Webb, veterans benefits researcher. Verified against current 38 CFR regulations and PACT Act provisions. Last reviewed: July 2026. Not legal advice — for representation, connect with a VA-accredited attorney.